Phoenix Tissue Repair

Phoenix Tissue Repair Focuses on Advancing New Therapies for Dystrophic Epidermolysis Bullosa. It is advancing an investigational therapy called PTR-01, a systemic recombinant collagen type VII (rC7), for the treatment of recessive dystrophic epidermolysis bullosa, a rare skin disease caused by the deficiency of human type VII collagen.